MetaCap

Telomir Pharmaceuticals Insider Trades

NASDAQ: TELOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.364-0.0758 (-17.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Telomir Pharmaceuticals insider activity

Over the last 12 months, Telomir Pharmaceuticals insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Aminov Erez (CEO and Chairman) reporting a transaction in 7,319,710 shares at $1.37 on Apr 22, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TELO's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TELO insider transactions

Telomir Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Apr 22, 2026Aminov ErezCEO and Chairmanother7,319,710$10.03MForm 4
Feb 13, 2024Bay Shore Trust & McNulty Brian Patrick10% OwnerBuy49,000$343.00KForm 4
Feb 13, 2024Bay Shore Trust & McNulty Brian Patrick10% OwnerBuy40,000$280.00KForm 4
Feb 13, 2024Bay Shore Trust & McNulty Brian Patrick10% OwnerBuy49,000$343.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related